Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FZD8 anticorps (AA 55-233)

FZD8 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7153193
  • Antigène Voir toutes FZD8 Anticorps
    FZD8 (Frizzled Family Receptor 8 (FZD8))
    Épitope
    • 5
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 55-233
    Reactivité
    • 53
    • 43
    • 31
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 51
    • 3
    • 1
    • 1
    Lapin
    Clonalité
    • 47
    • 9
    Polyclonal
    Conjugué
    • 25
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp FZD8 est non-conjugé
    Application
    • 36
    • 14
    • 12
    • 11
    • 9
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain, Souris
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Frizzled-8 protein (55-233AA)
    Isotype
    IgG
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    FZD8 (Frizzled Family Receptor 8 (FZD8))
    Autre désignation
    FZD8 (FZD8 Produits)
    Synonymes
    anticorps FZ-8, anticorps hFZ8, anticorps FZD8, anticorps Fz-8, anticorps frizzled8, anticorps xfz8, anticorps Xfz8, anticorps frizzled-8, anticorps hfz8, anticorps Fz8, anticorps fzd8, anticorps fz5, anticorps fz8a, anticorps fzc, anticorps wu:fd02c05, anticorps zg05, anticorps ZG06, anticorps Zfz8b, anticorps fz6, anticorps fz8b, anticorps fzA, anticorps ik:tdsubc_1e1, anticorps xx:tdsubc_1e1, anticorps zfzA, anticorps frizzled class receptor 8, anticorps frizzled class receptor 8 S homeolog, anticorps frizzled class receptor 8 L homeolog, anticorps frizzled class receptor 8a, anticorps frizzled class receptor 8b, anticorps FZD8, anticorps fzd8.S, anticorps fzd8, anticorps Fzd8, anticorps fzd8.L, anticorps fzd8a, anticorps fzd8b
    Sujet

    Background: Receptor for Wnt proteins. Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. The beta-catenin canonical signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Coreceptor along with RYK of Wnt proteins, such as WNT1.

    Aliases: Frizzled 8 seven transmembrane spanning receptor antibody, frizzled 8, seven transmembrane spanning receptor antibody, Frizzled family receptor 8 antibody, frizzled homolog 8 (Drosophila) antibody, Frizzled homolog 8 antibody, Frizzled-8 antibody, FZ 8 antibody, Fz-8 antibody, FZ8 antibody, FZD 8 antibody, FZD8 antibody, FZD8_HUMAN antibody, hFZ 8 antibody, hFz8 antibody, HGNC4046 antibody, Homolog of Drosophila Frizzled 8 antibody

    UniProt
    Q9H461
    Pathways
    Signalisation WNT
Vous êtes ici: